NEW YORK (GenomeWeb News) – DDC Medical has signed a licensing agreement with the National Institute of Standards and Technology to commercialize mouse cell line authentication using STR DNA technology, the firm announced today.
The DDC mouse cell line authentication test uses STR DNA analysis for mouse DNA characterization, and the loci that are selected produce "stable robust results based on a tetranucleotide repeat, similar to the types of loci examined for human cell line authentication," the company said.
It noted that while other mouse cell line tests use dinucleotide repeat STR loci that may be difficult to interpret, or large SNP arrays that are both expensive and time-consuming, its mouse cell line authentication test is inexpensive and has a short turnaround time.
Mouse cell lines are becoming a common method for studying human diseases, and in a statement, DDC CSO Michael Baird said, "The addition of mouse cell line authentication is a major step in maintaining the efficacy of biomedical research using cell lines."
Financial and other terms of the deal were not disclosed.
Fairfield, Ohio-based DDC provides DNA testing services for paternity and other family relationships, forensics, cell line authentication, and ancestry.